# Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus

> **NCT03875755** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1080 (estimated)

## Conditions studied

- Gestational Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Myo Inositol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03875755
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-04
- **Primary completion:** 2026-09-20
- **Final completion:** 2027-01-20
- **Target enrollment:** 1080 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03875755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03875755, "Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03875755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*